Home / For clinicians / Prescribing guides
Prescribing guides, A to Z
35 drugs so far, listed by brand name. Each guide covers the dispensing gate, PA documentation, titration, monitoring and interactions.
Every drug, A to Z
For when you know the drug. To compare the drugs for one condition side by side, start from Conditions instead.
A
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl (efanesoctocog alfa))Hemophilia A · Dosing, Inhibitors and PANo REMS and no boxed warning; prior authorization, HemAssist enrollment online or by fax, specialty pharmacy shipment and IV infusion training before the first home dose.Amvuttra (vutrisiran)ATTR amyloidosis with cardiomyopathy (ATTR-CM) · Dosing, Vitamin A and PA CriteriaNo REMS. A Start Form to Alnylam Assist signed by patient and prescriber, which also carries the prescription; prior authorization; a site of care, from office or infusion center to home nursing where coverage allows; administration by a healthcare professional.Atebrioz (zilurgisertib)Fibrodysplasia ossificans progressiva · Dosing, Pregnancy Testing, Interactions and PANo REMS; verify no pregnancy in females of reproductive potential, reconcile strong CYP3A4 inhibitors, CYP3A4 inducers and MATE1 or MATE2-K substrates, fax the MAP Patient Enrollment Form with both sides of the insurance card to 1-855-282-4884, and the MAP pharmacy confirms shipping before the first bottle.Attruby (acoramidis)ATTR amyloidosis with cardiomyopathy (ATTR-CM) · Dosing, Interactions and PA CriteriaNo REMS; specialty dispensing through Orsini, PANTHERx Rare or select health system pharmacies after prior authorization; ForgingBridges Start Form and patient consent faxed to 1-877-738-0545, or eRx to RareMed Solutions.C
Camzyos (mavacamten)Obstructive hypertrophic cardiomyopathy · REMS, Echo Schedule and PA CriteriaREMS-certified prescriber and pharmacy, Patient Enrollment Form carrying the baseline echo with LVEF 55% or higher, a negative pregnancy test where it applies, and the pharmacy's medication review; the REMS authorizes every fill.Cerezyme (imiglucerase)Gaucher disease · Dosing, Infusion Volumes, PA CriteriaNo REMS. Boxed warning: initiate in a healthcare setting with monitoring and CPR equipment. Prior authorization and a site of care before the first infusion.E
Elfabrio (pegunigalsidase alfa-iwxj)Fabry disease · Dosing, Infusion Rates and PA CriteriaNo REMS. Prior authorization, Elfabrio Start Form, a site with CPR-capable medical support for initial infusions, and premedication planned case by case.Empaveli (pegcetacoplan)Paroxysmal nocturnal hemoglobinuria (PNH) · REMS, Vaccines and PA CriteriaREMS-certified prescriber, pneumococcal and meningococcal (ACWY and B) vaccination at least 2 weeks before day 1 or antibacterial prophylaxis with vaccines as soon as possible, no unresolved encapsulated bacterial infection, counseling with the Patient Guide and Patient Safety Card, and the pharmacy's documentation of vaccination status with the office.Enspryng (satralizumab-mwge)Neuromyelitis optica spectrum disorder (NMOSD) · Screening, Liver Labs and PA CriteriaNo REMS. HBV, TB and liver transaminase plus bilirubin screening before dose 1, live vaccines at least 4 weeks before, ENSPRYNG Start Form, prior authorization, and HCP-guided first injection.F
Fabhalta (iptacopan)IgA nephropathy · Vaccines, REMS and PA CriteriaREMS-certified prescriber, pneumococcal and meningococcal (ACWY and B) vaccination at least 2 weeks before day 1 or antibacterial prophylaxis with vaccines as soon as possible, counseling with the Patient Safety Card, and the pharmacy's documentation of vaccination status with the office.Fabrazyme (agalsidase beta)Fabry disease · Dosing, Infusion Rate and PA CriteriaNo REMS. Boxed warning: initiate in a healthcare setting with monitoring and CPR equipment. Prior authorization and a site of care before the first infusion.Fayuvi (rebisufligene etisparvovec-hopf)Sanfilippo syndrome type A · AAV9 Testing, Steroids, Monitoring and PANo REMS; administration at an Ultragenyx Qualified Treatment Center after anti-AAV9 total binding antibody titer below 1:100, baseline ALT, AST, GGT, bilirubin, platelets, PT and aPTT, infection control, no vaccines in the prior 30 days, a negative serum pregnancy test where applicable, and prednisone or prednisolone started the day before.Filspari (sparsentan)IgA nephropathy · REMS, Liver Tests and PA CriteriaREMS-certified prescriber and pharmacy, REMS enrollment form, baseline ALT, AST and bilirubin, and a negative pregnancy test where it applies, before the first ship.G
Galafold (migalastat)Fabry disease · Amenability, Dosing and PA CriteriaNo REMS; Galafold Referral Form (also a prescription in some states) with patient consent to Amicus Assist by fax 1-833-264-2873 or email assist@amicusrx.com; specialty pharmacy ships after any prior authorization.H
Hemlibra (emicizumab-kxwh)Hemophilia A · Dosing, aPCC Warning and PANo REMS; specialty pharmacy, treatment center or hospital pharmacy dispensing after prior authorization; HEMLIBRA Access Solutions starts only once both the Prescriber Service Form and the Patient Consent Form are received.I
Imaavy (nipocalimab-aahu)Generalized myasthenia gravis · Dosing, Infusion Monitoring and PANo REMS. Prior authorization, age-appropriate vaccines before initiation, a site of care (office, infusion center or home), and no active infection on each dose day.K
Kesimpta (ofatumumab)Relapsing multiple sclerosis (MS) · HBV Screening, Loading Doses and PANo REMS. HBV, quantitative immunoglobulin and liver tests before dose 1, live vaccines at least 4 weeks and inactivated at least 2 weeks before when possible, prior authorization, a supervised first injection, and no active infection on each dose day.L
Livdelzi (seladelpar)Primary biliary cholangitis (PBC) · Dosing, Liver Monitoring, Interactions, PANo REMS; baseline clinical and laboratory liver assessment, a check for decompensated cirrhosis, a medication review against the interaction table, prior authorization, and routing to a specialty pharmacy in Gilead's network.M
Myqorzo (aficamten)Obstructive hypertrophic cardiomyopathy · REMS, Echo Titration and PA CriteriaREMS-certified prescriber and pharmacy, Patient Guide counseling, a baseline echocardiogram with LVEF 55% or higher, and a Patient Enrollment Form signed by patient and prescriber, with treatment started within 3 months of the form; the REMS authorizes every fill.P
Palsonify (paltusotine)Acromegaly · IGF-1 Titration and PA CriteriaNo REMS; specialty dispensing through Biologics by McKesson, Orsini or select pituitary centers after prior authorization; CrinetiCARE product enrollment form faxed to 844-CRN-FAXX (844-276-3299).Q
Qalsody (tofersen)ALS with a SOD1 mutation · Intrathecal Dosing, Warnings and PANo REMS and no lab gate; a documented SOD1 mutation, a site with clinicians experienced in lumbar puncture, prior authorization, and pre- and post-procedure evaluation at each dose.R
Rystiggo (rozanolixizumab-noli)Generalized myasthenia gravis · Dosing Cycles, Administration and PANo REMS. Prior authorization, ONWARD Start Form with antibody report, healthcare provider administration only (office, infusion center, hospital outpatient or home infusion nurse), limited specialty pharmacy network or buy and bill, and no active infection on each dose day.S
Sandostatin LAR Depot (octreotide acetate)Acromegaly · Switching and PA CriteriaNo REMS. Documented response to and tolerance of Sandostatin injection (at least 2 weeks for octreotide-naive patients, judged by GH and IGF-1); prior authorization, usually under the medical benefit; administration by a trained healthcare provider.Sohonos (palovarotene)Fibrodysplasia ossificans progressiva · Pregnancy Rules, Growth X-rays, PA CriteriaEffective contraception from at least 1 month before the first dose and a negative serum pregnancy test within 1 week before it, in females of reproductive potential; baseline skeletal maturity in growing patients; IPSEN CARES enrollment, benefits verification and routing to a limited specialty pharmacy network. No REMS.Somatuline Depot (lanreotide)Acromegaly · Titration and PA CriteriaNo REMS. IPSEN CARES enrollment started by the office with the patient's signed authorization; prior authorization; specialty pharmacy or buy and bill; administration by a healthcare provider in the office or another site of care.T
Tarpeyo (budesonide delayed-release capsules)IgA nephropathy · Dosing, 9-Month Course and PA CriteriaTarpeyo Touchpoints enrollment form signed by patient and prescriber, hepatitis B screen, and the prescription routed to PANTHERx Rare Pharmacy, the only dispensing pharmacy.Trutakna (atacicept)IgA nephropathy · Dosing, Vaccines and PA CriteriaNo REMS and no lab gate; assess for active infection, complete age-appropriate vaccines with any live vaccine more than 30 days before day 1, submit the Tru Support enrollment and prescription form, and the specialty pharmacy must reach the patient before it ships.U
Ultomiris (ravulizumab-cwvz)IgA nephropathy · Vaccines, REMS, Dosing and PA CriteriaREMS-certified prescriber, MenACWY and MenB vaccination completed or updated at least 2 weeks before day 1 or antibacterial prophylaxis with vaccines as soon as possible, counseling with the Patient Safety Card, and a REMS-certified healthcare setting or pharmacy that verifies prescriber certification.Uplizna (inebilizumab-cdon)Neuromyelitis optica spectrum disorder (NMOSD) · Pre-Infusion Screening and PA CriteriaNo REMS. HBV, quantitative immunoglobulin and TB screening before dose 1, immunizations at least 4 weeks before, prior authorization, a site of care, and no active infection on each dose day.V
Vanrafia (atrasentan)IgA nephropathy · Liver and Pregnancy Tests, PA CriteriaNo REMS. Baseline liver enzymes, a negative pregnancy test where it applies, the Start Form to Novartis Patient Support, and the prescription routed to a specialty pharmacy (CareMed or Biologics, or the plan's own).Voyxact (sibeprenlimab)IgA nephropathy · Dosing, Infection Screening and PA CriteriaNo REMS and no lab gate; assess for active infection, give any live vaccine more than 30 days before day 1, send the Prescription Start Form with the patient's signed consents to PANTHERx Rare, and the pharmacy contacts the patient before it ships.Vyndamax (tafamidis)ATTR amyloidosis with cardiomyopathy (ATTR-CM) · Dosing, Conversion and PA CriteriaNo REMS; prior authorization where the plan requires it, a specialty pharmacy in the plan's network, and shipment to the patient's home once approved.Vyvgart (efgartigimod alfa)Generalized myasthenia gravis · Dosing Cycles, Sites of Care and PANo REMS. Prior authorization, a site of care (infusion center, office, home nurse, or prefilled syringe self-injection after specialty pharmacy training), and no active infection on each dose day.W
Wayrilz (rilzabrutinib)Immune thrombocytopenia (ITP) · Dosing, Liver Monitoring and PA CriteriaNo REMS; baseline bilirubin, transaminases and pregnancy status before the first dose; HemAssist enrollment online or by fax to 1-855-398-7634; prior authorization; HemAssist triages the prescription to the patient's specialty pharmacy.Z
Zilbrysq (zilucoplan)Generalized myasthenia gravis · REMS, Vaccine Timing and PA CriteriaREMS-certified prescriber; meningococcal ACWY and B vaccination at least 2 weeks before day 1, or antibacterial prophylaxis with vaccines as soon as possible; baseline lipase and amylase; counseling with the Patient Guide and Safety Card; dispensing only through PANTHERx Rare after it documents vaccination status with the office.